LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

ARase Therapeutics

ARase Therapeutics is a newly formed, science-focused oncology company developing first-in-class drugs that modulate cell signaling pathways. We are seeking highly motivated, intelligent and creative individuals who want to make an early and lasting impact on an actively growing company.

  • Paul Chang President, CEO / CSO and founder
  • Lisa Ames Protein and Assay Biology
  • Muzhou Wu Translational Biology
  • Katherine Widdowson Chemistry